Clinical Trial Update: Phase II Trial of Pembrolizumab in Metastatic or Locally Advanced Anaplastic/Undifferentiated Thyroid Cancer [Phase 2]

View source ↗

Summary

This entry reports an ongoing Phase II clinical trial evaluating pembrolizumab in patients with metastatic or locally advanced anaplastic/undifferentiated thyro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anaplastic Thyroid Carcinoma

Drugs mentioned

• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: Stanford University | Conditions: Thyroid Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING